Koike, Y.; Kuwatsuka, S.; Nishimoto, K.; Motooka, D.; Murota, H.
Skin Mycobiome of Psoriasis Patients is Retained during Treatment with TNF and IL-17 Inhibitors. Int. J. Mol. Sci. 2020, 21, 3892.
https://doi.org/10.3390/ijms21113892
AMA Style
Koike Y, Kuwatsuka S, Nishimoto K, Motooka D, Murota H.
Skin Mycobiome of Psoriasis Patients is Retained during Treatment with TNF and IL-17 Inhibitors. International Journal of Molecular Sciences. 2020; 21(11):3892.
https://doi.org/10.3390/ijms21113892
Chicago/Turabian Style
Koike, Yuta, Sayaka Kuwatsuka, Katsutaro Nishimoto, Daisuke Motooka, and Hiroyuki Murota.
2020. "Skin Mycobiome of Psoriasis Patients is Retained during Treatment with TNF and IL-17 Inhibitors" International Journal of Molecular Sciences 21, no. 11: 3892.
https://doi.org/10.3390/ijms21113892
APA Style
Koike, Y., Kuwatsuka, S., Nishimoto, K., Motooka, D., & Murota, H.
(2020). Skin Mycobiome of Psoriasis Patients is Retained during Treatment with TNF and IL-17 Inhibitors. International Journal of Molecular Sciences, 21(11), 3892.
https://doi.org/10.3390/ijms21113892